Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2020 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
The following terms were ignored: %, %, %
The following terms were not found in PubMed: 20EL, 5BAuthor
Page 1
Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study).
BMJ Open. 2022 May 3;12(5):e062599. doi: 10.1136/bmjopen-2022-062599.
BMJ Open. 2022.
PMID: 35504634
Free PMC article.
Other secondary outcome measures are patient global assessments of disease activity, disease flares and their treatment, EuroQol 5- dimention 5-level (EQ-5D-5L), self-reported adherence with advice to interrupt or continue methotrexate, neutralising antibody titre against …
Other secondary outcome measures are patient global assessments of disease activity, disease flares and their treatment, EuroQol 5- dimentio …
Progressive exercise compared with best practice advice, with or without corticosteroid injection, for the treatment of rotator cuff disorders: statistical analysis plan for the Getting it Right: Addressing Shoulder Pain (GRASP) 2 × 2 factorial multicentre randomised controlled trial.
Marian IR, Hopewell S, Keene DJ, Cureton L, Lamb SE, Dutton SJ.
Marian IR, et al.
Trials. 2020 Sep 7;21(1):767. doi: 10.1186/s13063-020-04704-5.
Trials. 2020.
PMID: 32894159
Free PMC article.
Clinical Trial.
Secondary outcomes are as follows: pain and function SPADI subdomains, health-related quality of life (EuroQol EQ-5D-5L), sleep disturbance, return to activity, global impression of change, health resource use, out-of-pocket expenses and work disability. ...
Secondary outcomes are as follows: pain and function SPADI subdomains, health-related quality of life (EuroQol EQ-5D-5L), sleep distu …
Item in Clipboard
Clinical and cost-effectiveness of progressive exercise compared with best practice advice, with or without corticosteroid injection, for the treatment of rotator cuff disorders: protocol for a 2x2 factorial randomised controlled trial (the GRASP trial).
Hopewell S, Keene DJ, Maia Schlüssel M, Dritsaki M, Dutton S, Carr A, Hamilton W, Hansen Z, Jaggi A, Littlewood C, Soutakbar H, Heine P, Cureton L, Barker K, Lamb SE.
Hopewell S, et al.
BMJ Open. 2017 Jul 17;7(7):e018004. doi: 10.1136/bmjopen-2017-018004.
BMJ Open. 2017.
PMID: 28716796
Free PMC article.
Clinical Trial.
Secondary outcomes are: pain and function SPADI subdomains; health-related quality of life (Five-Level version of the EuroQol EQ-5D-5L); sleep disturbance; return to activity; global impression of change; health resource use; out-of-pocket expenses; work disability. ...
Secondary outcomes are: pain and function SPADI subdomains; health-related quality of life (Five-Level version of the EuroQol EQ-5D-5 …
Item in Clipboard
Cite
Cite